What is Saffron used for?

Saffron is the dried red stigmas of the Crocus sativus flower, whose carotenoid crocin and the volatile compound safranal are regarded as its main active constituents. Beyond culinary use, it is studied for mood: a meta analysis of randomized clinical trials in adults with major depressive disorder found that saffron supplementation reduced depression symptoms relative to placebo and performed comparably to antidepressant medication in the trials reviewed. Most studies were small, short, and conducted in a single region, so larger independent trials are needed. Very high doses of saffron can be toxic.

Herb Profile

Saffron

Crocus sativus

Saffron is the dried red stigmas of the Crocus sativus flower, whose carotenoid crocin and the volatile compound safranal are regarded as its main active constituents.

Last reviewed: June 6, 2026•3 sources citedReport a correctionProfile-wide ·C Limited

Use extra caution — High doses may cause GI/CNS effects and uterine stimulation; avoid pregnancy level medicinal dosing; monitor with serotonergic drugs. Details

Evidence: Limited Evidence
Typical onset: Varies by prep
Safety rating: High caution
Best for: Mood Support, Antidepressant, Anti Anxiety, Stress
Avoid / review if: Pregnancy/Breastfeeding Without Clinician Supervision, Known Allergy To The Plant/Family, Use Caution With Serotonergic Medications And Anticoagulants.

The Hippie Scientist

Verdict: SaffronMaybe

Best for

Low mood and mild depressive symptoms
Mood support with a food-grade botanical

Not ideal for

Acute anxiety relief
A sleep aid
Replacing prescribed treatment

Evidence confidence: Moderate for mood — a genuinely interesting evidence base
Expected onset: 2–4 weeks
Give it: 6–8 weeks

Bottom line: One of the more compelling botanicals for mild low mood, with several controlled trials. It works slowly and is a support, not a substitute for care.

Safety: High doses can cause side effects; keep to culinary/standardized amounts and involve a clinician for depression.

On the evidence: Multiple randomized trials for depressive symptoms, mostly small and short.

How strong is the evidence?Moderate

Why not higher

Trials are small, short, and often industry-linked
Standardized extracts differ from culinary saffron
Long-term data is limited

Why not lower

Multiple randomized, placebo-controlled trials for mild low mood
Effects are directionally consistent across studies

Practical takeaway: A reasonable food-grade option for mild low mood over 6–8 weeks. It is a support, not a substitute for care — involve a clinician for depression.

Next stepsWhere to go next — guides & comparisons

Start here

New to this? Begin with Natural anxiety & mood relief.

Compare first

Beyond ashwagandha: other anxiolytics — if mood overlaps with anxiety

If you want help with anxiety or stress → Anxiety & stress guides
If you want to browse more herbs → All herbs

Safety

Safety & Cautions

High doses may cause GI/CNS effects and uterine stimulation; avoid pregnancy level medicinal dosing; monitor with serotonergic drugs.

High caution

Caution level: High. Multiple caution categories apply, or the record uses avoid/contraindication language.

Interaction-AwareMedication or interaction context is explicitly noted.
Pregnancy/Breastfeeding CautionPregnancy or breastfeeding caution language is present.

Detailed safety fields

Pregnancy, breastfeeding, and contraindications

Pregnancy/Breastfeeding Without Clinician Supervision
Known Allergy To The Plant/Family
Use Caution With Serotonergic Medications And Anticoagulants.

Safety classifications

Interaction-Aware: Medication or interaction context is explicitly noted.
Pregnancy/Breastfeeding Caution: Pregnancy or breastfeeding caution language is present.

Full safety note

High doses may cause GI/CNS effects and uterine stimulation; avoid pregnancy level medicinal dosing; monitor with serotonergic drugs.

Safety labels

Interaction-Aware
Pregnancy/Breastfeeding Caution

Evidence-based safety

Caution when combined

Severity and certainty are shown separately. A high-priority caution can still be theoretical: these pairings are screened from shared contraindication mechanisms and are not automatically documented clinical interactions. Provenance identifies the source fields that produced each flag; it does not upgrade the certainty of the pairwise claim.

High-Priority Caution

173 flagged pairings

Serotonergic activity · Bleeding / anticoagulant risk

Representative pairings are shown below. Large mechanism groups are intentionally summarized to keep profiles focused and crawl-efficient.

Serotonergic activityCertainty: Theoretical

Data provenance recorded for 26 of 26 pairings in this mechanism group.

5-HTP — Theoretical interaction certainty
Caffeine — Theoretical interaction certainty
crocetin — Theoretical interaction certainty
crocin — Theoretical interaction certainty
Crocus Sativus — Theoretical interaction certainty
Damiana — Theoretical interaction certainty
DMT — Theoretical interaction certainty
Ginkgo — Theoretical interaction certainty
Panax Red Ginseng — Theoretical interaction certainty
Panax White Ginseng — Theoretical interaction certainty
Harmaline — Theoretical interaction certainty
Harmine — Theoretical interaction certainty

+14 more pairings share this mechanism. Use the Safety Checker to review a specific combination.

Bleeding / anticoagulant riskCertainty: Theoretical

Data provenance recorded for 147 of 147 pairings in this mechanism group.

+135 more pairings share this mechanism. Use the Safety Checker to review a specific combination.

Evidence

Evidence Summary

Evidence lens

Read as directional context, not settled clinical proof.

LimitedLimited Evidence

Human clinical evidence: Present in source signals

Mechanistic / preclinical: Mechanism mapped — Inflammatory Signaling Modulation · Oxidative Stress Modulation · Neurotransmitter Modulation

Research maturity: Emerging research — Long Term Human Evidence May Be Limited.

Safety boundary: Safety note available — High doses may cause GI/CNS effects and uterine stimulation; avoid pregnancy level medicinal dosing; monitor with serotonergic drugs.

This profile cites 3 human studies.

Study design details

Evidence Grade

Grade C: Limited Evidence

Evaluation of methodological rigor, population reach, and evidence alignment.

Design Match: Meta-analysis
Risk of Bias: Low
Consistency: Consistent

Strongest recorded design is a meta-analysis, drawn from 7 recorded studies, 7 in people. No disagreement is recorded across them.

How evidence grades work

Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.

Strong: Multiple RCTs, consistent direction, adequate effect size
Moderate: Some RCTs or consistent observational data in humans
Preliminary / Mixed: Animal or in-vitro only, or conflicting human data
Traditional / Theoretical: Traditional use only; no controlled human trials

Clinical Study Summaries (7)7 human evidence sources · 3 human trials · ~118 participants across 1 human evidence source with reported N · Consistency not yet classifiable

Filter by study class

Showing 7 of 7 studies.

What the evidence actually shows

This table contains 7 structured sources, including 7 human evidence sources; 3 are human trials. Across 1 human evidence source with a reported sample size, the approximate participant total is 118; overlapping publications may include some of the same people.

Study	Design	N	Dose	Duration	Population	Outcome	Result & magnitude	Source
Effect of saffron on depression, anxiety and mood disorder: a GRADE assessed systematic review and meta-analysis of 34 randomized controlled trials Background	Meta-analysis Statistically combines results from multiple eligible studies; confidence still depends on the quality, consistency, and directness of those studies.	—	—	—	—	—	BDI and BAI outcomes favored saffron, while HDRS, HARS, and POMS outcomes were not consistently significant. \| Saffron reduced BDI scores (WMD -4.39, 95% CI -6.64 to -2.15) and BAI scores (WMD -5.06, 95% CI -8.44 to -1.68).	PubMed →
Effect of Saffron Versus Selective Serotonin Reuptake Inhibitors (SSRIs) in Treatment of Depression and Anxiety: A Meta-analysis of Randomized Controlled Trials Background	Meta-analysis Statistically combines results from multiple eligible studies; confidence still depends on the quality, consistency, and directness of those studies.	—	—	—	—	—	Saffron did not differ significantly from SSRIs on pooled efficacy outcomes, while adverse events favored saffron. \| No significant difference between saffron and SSRIs for depression (SMD 0.10, 95% CI -0.09 to 0.29) or anxiety (SMD 0.04, 95% CI -0.22 to 0.29).	PubMed →
The Effects of Crocus sativus (Saffron) on ADHD: A Systematic Review Seyedi-Sahebari S et al. · J Atten Disord · 2024 Background	Systematic review Uses a predefined method to find and evaluate relevant studies, but may or may not pool their results statistically.	n=118	—	—	—	—	—	PubMed →
Herbal medicine for depression and anxiety: A systematic review with assessment of potential psycho-oncologic relevance Yeung KS et al. · Phytother Res · 2018 Background	Systematic review Uses a predefined method to find and evaluate relevant studies, but may or may not pool their results statistically.	—	—	—	—	—	—	PubMed →
An Examination into the Effects of a Saffron Extract (Affron) on Mood and General Wellbeing in Adults Experiencing Low Mood: A Randomized, Double-Blind, Placebo-Controlled Trial Background	Randomized controlled trial Randomly assigns participants to interventions or controls, reducing many sources of bias when the trial is conducted well.	—	—	—	—	—	The primary depression outcome improved, but many broader secondary wellbeing outcomes did not clearly differ from placebo.	PubMed →
The effects of a saffron extract (Affron®) on mood, sleep, self-esteem, and exploratory measures of physical appearance in women aged 50 to 70 years experiencing low mood and poor sleep: a randomised, double-blind, placebo-controlled trial Background	Randomized controlled trial Randomly assigns participants to interventions or controls, reducing many sources of bias when the trial is conducted well.	—	—	—	—	—	28 mg/day for 12 weeks improved depression-related scores, self-esteem, and sleep-related impairment versus placebo.	PubMed →

Show 1 more study

Effectivity of Saffron Extract (Saffr'Activ) on Treatment for Children and Adolescents with Attention Deficit/Hyperactivity Disorder (ADHD): A Clinical Effectivity Study

Blasco-Fontecilla H et al. · Nutrients · 2022

Background

Controlled trial

Compares an intervention with a control group but may lack random assignment or other safeguards of a strong randomized trial.

—

PubMed →

Dosing & Timing

No standardized dose: Preparation specific; use standardized product label for Threads or standardized extract and require source backed dosage review before therapeutic claims.

How Saffron works

Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.

Mechanism Pathway — How Saffron Works

CompoundTarget / ReceptorMechanismEffect / Outcome

Mechanisms & biological pathways (preclinical)

Inflammatory Signaling Modulation
Oxidative Stress Modulation
Neurotransmitter Modulation
Stress Response Modulation

Active Compounds

Key constituents studied in Saffron, with full pharmacology and safety profiles.

Compare related active botanicals

Explore botanicals with similar chemistry, effects, or safety considerations in the Botanical Activity Atlas.

Guides that use Saffron

Condition guides

Compare & Sourcing

Compare side-by-side tradeoffs or verify active marker guidelines.

Sourcing options

Saffron product picks

Recommendation status

Product recommendations are not shown for this profile because the current site safety and monetization policy does not permit them.

Product form & quality guidelines

When sourcing Saffron, verify the label for:

Standardized extract: Confirm active content percentages on the supplement facts panel (e.g. standardized to specific marker compounds) rather than simple raw herb weights.
Third-party testing: Look for independent purity labels (USP, NSF, ConsumerLab, or Eurofins) to ensure the product is free from heavy metals, solvents, and contaminants.
Form bioavailability: Ensure the form matches evidence-supported configurations (e.g. standardized active extracts like bacosides, withanolides, or curcuminoids) for optimal onset and digestion tolerance.

Continue comparing

Safety first · Harm reduction

This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.

Learn how we evaluate confidence, safety, and intensity on the methodology page.

Editorial Review

Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.

Editorial Standards →

Help improve this profile

Was this useful for your research?

These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.

Was this evidence summary clear?

Did you find what you were researching?

Suggest an ingredient, comparison, or study →

Free safety checklist

Get the Saffron research notes

Evidence summaries, dosing context, and safety updates for this herb — straight to your inbox.

We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.

← Back to herbs library Safety checker →